Business ❯Pharmaceuticals ❯AstraZeneca

Financial Performance

Revenue Growth Sales Guidance Profits Earnings per Share

AstraZeneca Reports Strong 2024 Results While Facing China Tax Probe

AstraZeneca Projects Strong Growth in 2024 Despite COVID-19 Sales Dip